Oropharyngeal Cancer Treatment
June 30, 2024
Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology Oropharyngeal Cancer | Otolaryngology\u2060 — Head & Neck Surgery | Stanford Medicine Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial | BMC Cancer | Full Text Oropharyngeal Cancer Treatment
.jpg){kind=link}
